Andy Coravos

Andy Coravos's Title

Andy Coravos is the Co-Founder and CEO of HumanFirst. In her role, she leads the company’s strategic vision and oversees its day-to-day operations. Her leadership focuses on integrating cutting-edge research and technological advancements to enhance the company's offerings in the healthcare and digital health sectors. As CEO, Andy is responsible for steering HumanFirst towards achieving its mission of improving healthcare outcomes through the adoption of innovative digital tools.

Andy Coravos's Company

Andy Coravos co-founded HumanFirst, a company dedicated to advancing the adoption of digital biomarkers and other innovative technologies in healthcare. HumanFirst aims to improve clinical trials and patient outcomes by leveraging evidence-based digital tools. The company is at the forefront of integrating digital health solutions into study protocols, making healthcare more efficient and personalized. Under Andy's leadership, HumanFirst is committed to pushing the boundaries of what is possible in the realm of digital health.

Andy Coravos's Contributions to Research

Andy Coravos has made significant contributions to the latest research led by the HumanFirst team. Her work focuses on the integration of digital biomarkers into clinical study protocols, which is a groundbreaking approach in modern healthcare research. By contributing to this cutting-edge research, Andy is helping to lay the groundwork for more precise and efficient healthcare solutions. Her involvement underscores her commitment to evidence-based practices and the advancement of digital health technologies.

Andy Coravos's Expertise in Digital Biomarkers

Andy Coravos has written extensively about the adoption of evidence-based digital biomarkers in study protocols. Her expertise in this area highlights the importance of using digital tools to gather accurate and actionable health data. Andy's writings provide valuable insights into how digital biomarkers can enhance the accuracy of clinical trials and improve patient outcomes. Her thought leadership in this field is instrumental in driving the adoption of these innovative technologies in mainstream healthcare.